Related Experiment Video
Updated: Jul 17, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study
G A Kennedy1, J Morton, R Western
1Department of Haematology, Royal Brisbane Hospital, Brisbane, Australia.
Insights
Bone marrow donation caused more localized pain than peripheral blood stem cell (PBSC) collection, but did not delay recovery. Few bone marrow donors experienced chronic pain, and no serious long-term G-CSF related complications were found.
Area of Science:
- Hematology
- Transplantation Medicine
- Clinical Research
Background:
- Allogeneic stem cell transplantation relies on donor stem cell sources.
- Granulocyte-colony stimulating factor (G-CSF) is used to mobilize peripheral blood stem cells (PBSCs).
- Bone marrow (BM) donation is an alternative stem cell source.
Purpose of the Study:
- To compare donor morbidity and long-term complications between BM and G-CSF stimulated PBSC donation procedures.
- To assess the impact of donation type on donor pain and recovery.
- To identify any chronic side effects associated with G-CSF stimulated PBSC donation.
Main Methods:
- A questionnaire was administered to donors participating in a comparative trial of BM versus PBSC donation.
- Data collected focused on donor-reported pain, recovery time, and long-term complications.
- Statistical analysis compared outcomes between the two donation groups.
Main Results:
- Bone marrow donors reported significantly more localized pain at the donation site compared to PBSC donors.
- This increased pain did not result in a longer delay for bone marrow donors to return to normal activities.
- A small percentage of bone marrow donors experienced chronic pain post-donation.
- No significant long-term adverse effects were identified for G-CSF stimulated PBSC donation.
Conclusions:
- While bone marrow donation is associated with higher rates of acute localized pain, it does not impede donor recovery.
- Chronic pain is a potential, albeit infrequent, complication of bone marrow donation.
- G-CSF stimulated PBSC donation appears safe with no identified serious long-term complications.
Abstract:
As part of a previously reported trial comparing granulocyte-colony stimulating factor (G-CSF) stimulated bone marrow and peripheral blood stem cells (PBSCs) in allogeneic stem cell transplantation, we included a questionnaire to compare donor morbidity and long-term complications between the two donation procedures. Bone marrow donation was associated with significantly more donors experiencing localized pain at the donation site compared to PBSC collection. However, this was not associated with any increased delay in returning to normal activity. Although a minority of bone marrow donors suffered chronic pain at the donation site, no serious long-term side effects relating to G-CSF stimulated stem cell donation were identified.
Related Concept Videos
Source And Potency Of Stem Cells
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction

